All secondary endpoints including number of new lesions and total lesion volume on T2-weighted images , total number of Gd-enhancing lesions on T1-weighted images , volume of grey and white matter , EDSS , MSFC , relapse rate , number of relapse-free patients and neutralizing antibodies did not show significant differences either .